ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Follicle Stimulating Hormone Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-22P7856
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Follicle Stimulating Hormone Market Insights Forecast to 2028
BUY CHAPTERS

Global Recombinant Follicle Stimulating Hormone Market Research Report 2025

Code: QYRE-Auto-22P7856
Report
July 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck Serono
MSD
Techwell
GenSci
Gedeon Richter
TEVA

Recombinant Follicle Stimulating Hormone Market Size

The global market for Recombinant Follicle Stimulating Hormone was valued at US$ 1154 million in the year 2024 and is projected to reach a revised size of US$ 1680 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Recombinant Follicle Stimulating Hormone Market

Recombinant Follicle Stimulating Hormone Market

Recombinant FSH is produced through recombinant DNA technology. These products are pure and do not contain the "contaminants" seen in urine extraction FSH. It is given subcutaneously with much less discomfort. Both human and genetically derived products are difficult to obtain and manufacture and are therefore expensive.
North American market for Recombinant Follicle Stimulating Hormone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Follicle Stimulating Hormone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Recombinant Follicle Stimulating Hormone include Merck Serono, MSD, Techwell, GenSci, Gedeon Richter, Teva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Follicle Stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Follicle Stimulating Hormone.
The Recombinant Follicle Stimulating Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Follicle Stimulating Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Follicle Stimulating Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Follicle Stimulating Hormone Market Report

Report Metric Details
Report Name Recombinant Follicle Stimulating Hormone Market
Accounted market size in year US$ 1154 million
Forecasted market size in 2031 US$ 1680 million
CAGR 5.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 75IU
  • 150IU
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck Serono, MSD, Techwell, GenSci, Gedeon Richter, Teva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Follicle Stimulating Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Recombinant Follicle Stimulating Hormone Market growing?

Ans: The Recombinant Follicle Stimulating Hormone Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Recombinant Follicle Stimulating Hormone Market size in 2031?

Ans: The Recombinant Follicle Stimulating Hormone Market size in 2031 will be US$ 1680 million.

Who are the main players in the Recombinant Follicle Stimulating Hormone Market report?

Ans: The main players in the Recombinant Follicle Stimulating Hormone Market are Merck Serono, MSD, Techwell, GenSci, Gedeon Richter, Teva

What are the Application segmentation covered in the Recombinant Follicle Stimulating Hormone Market report?

Ans: The Applications covered in the Recombinant Follicle Stimulating Hormone Market report are Infertility Treatment, Assisted Reproductive Technology

What are the Type segmentation covered in the Recombinant Follicle Stimulating Hormone Market report?

Ans: The Types covered in the Recombinant Follicle Stimulating Hormone Market report are 75IU, 150IU, Others

Recommended Reports

Recombinant Protein Therapy

Reproductive Health Drugs

Hormone & Endocrine Therapies

1 Recombinant Follicle Stimulating Hormone Market Overview
1.1 Product Definition
1.2 Recombinant Follicle Stimulating Hormone by Type
1.2.1 Global Recombinant Follicle Stimulating Hormone Market Value Comparison by Type (2024 VS 2031)
1.2.2 75IU
1.2.3 150IU
1.2.4 Others
1.3 Recombinant Follicle Stimulating Hormone by Application
1.3.1 Global Recombinant Follicle Stimulating Hormone Market Value by Application (2024 VS 2031)
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Global Recombinant Follicle Stimulating Hormone Market Size Estimates and Forecasts
1.4.1 Global Recombinant Follicle Stimulating Hormone Revenue 2020-2031
1.4.2 Global Recombinant Follicle Stimulating Hormone Sales 2020-2031
1.4.3 Global Recombinant Follicle Stimulating Hormone Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Follicle Stimulating Hormone Market Competition by Manufacturers
2.1 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Follicle Stimulating Hormone Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Follicle Stimulating Hormone, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Follicle Stimulating Hormone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Follicle Stimulating Hormone, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Follicle Stimulating Hormone, Date of Enter into This Industry
2.8 Global Recombinant Follicle Stimulating Hormone Market Competitive Situation and Trends
2.8.1 Global Recombinant Follicle Stimulating Hormone Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Follicle Stimulating Hormone Players Market Share by Revenue
2.8.3 Global Recombinant Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Follicle Stimulating Hormone Market Scenario by Region
3.1 Global Recombinant Follicle Stimulating Hormone Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Follicle Stimulating Hormone Sales by Region: 2020-2031
3.2.1 Global Recombinant Follicle Stimulating Hormone Sales by Region: 2020-2025
3.2.2 Global Recombinant Follicle Stimulating Hormone Sales by Region: 2026-2031
3.3 Global Recombinant Follicle Stimulating Hormone Revenue by Region: 2020-2031
3.3.1 Global Recombinant Follicle Stimulating Hormone Revenue by Region: 2020-2025
3.3.2 Global Recombinant Follicle Stimulating Hormone Revenue by Region: 2026-2031
3.4 North America Recombinant Follicle Stimulating Hormone Market Facts & Figures by Country
3.4.1 North America Recombinant Follicle Stimulating Hormone Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Follicle Stimulating Hormone Sales by Country (2020-2031)
3.4.3 North America Recombinant Follicle Stimulating Hormone Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Follicle Stimulating Hormone Market Facts & Figures by Country
3.5.1 Europe Recombinant Follicle Stimulating Hormone Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Follicle Stimulating Hormone Sales by Country (2020-2031)
3.5.3 Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Follicle Stimulating Hormone Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Follicle Stimulating Hormone Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Follicle Stimulating Hormone Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Recombinant Follicle Stimulating Hormone Market Facts & Figures by Country
3.7.1 Latin America Recombinant Follicle Stimulating Hormone Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Follicle Stimulating Hormone Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Follicle Stimulating Hormone Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Follicle Stimulating Hormone Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Follicle Stimulating Hormone Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Follicle Stimulating Hormone Sales by Type (2020-2031)
4.1.1 Global Recombinant Follicle Stimulating Hormone Sales by Type (2020-2025)
4.1.2 Global Recombinant Follicle Stimulating Hormone Sales by Type (2026-2031)
4.1.3 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Follicle Stimulating Hormone Revenue by Type (2020-2031)
4.2.1 Global Recombinant Follicle Stimulating Hormone Revenue by Type (2020-2025)
4.2.2 Global Recombinant Follicle Stimulating Hormone Revenue by Type (2026-2031)
4.2.3 Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Follicle Stimulating Hormone Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Follicle Stimulating Hormone Sales by Application (2020-2031)
5.1.1 Global Recombinant Follicle Stimulating Hormone Sales by Application (2020-2025)
5.1.2 Global Recombinant Follicle Stimulating Hormone Sales by Application (2026-2031)
5.1.3 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Follicle Stimulating Hormone Revenue by Application (2020-2031)
5.2.1 Global Recombinant Follicle Stimulating Hormone Revenue by Application (2020-2025)
5.2.2 Global Recombinant Follicle Stimulating Hormone Revenue by Application (2026-2031)
5.2.3 Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Follicle Stimulating Hormone Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck Serono
6.1.1 Merck Serono Company Information
6.1.2 Merck Serono Description and Business Overview
6.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Serono Recombinant Follicle Stimulating Hormone Product Portfolio
6.1.5 Merck Serono Recent Developments/Updates
6.2 MSD
6.2.1 MSD Company Information
6.2.2 MSD Description and Business Overview
6.2.3 MSD Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
6.2.4 MSD Recombinant Follicle Stimulating Hormone Product Portfolio
6.2.5 MSD Recent Developments/Updates
6.3 Techwell
6.3.1 Techwell Company Information
6.3.2 Techwell Description and Business Overview
6.3.3 Techwell Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Techwell Recombinant Follicle Stimulating Hormone Product Portfolio
6.3.5 Techwell Recent Developments/Updates
6.4 GenSci
6.4.1 GenSci Company Information
6.4.2 GenSci Description and Business Overview
6.4.3 GenSci Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GenSci Recombinant Follicle Stimulating Hormone Product Portfolio
6.4.5 GenSci Recent Developments/Updates
6.5 Gedeon Richter
6.5.1 Gedeon Richter Company Information
6.5.2 Gedeon Richter Description and Business Overview
6.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Product Portfolio
6.5.5 Gedeon Richter Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Recombinant Follicle Stimulating Hormone Product Portfolio
6.6.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Follicle Stimulating Hormone Industry Chain Analysis
7.2 Recombinant Follicle Stimulating Hormone Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Follicle Stimulating Hormone Production Mode & Process Analysis
7.4 Recombinant Follicle Stimulating Hormone Sales and Marketing
7.4.1 Recombinant Follicle Stimulating Hormone Sales Channels
7.4.2 Recombinant Follicle Stimulating Hormone Distributors
7.5 Recombinant Follicle Stimulating Hormone Customer Analysis
8 Recombinant Follicle Stimulating Hormone Market Dynamics
8.1 Recombinant Follicle Stimulating Hormone Industry Trends
8.2 Recombinant Follicle Stimulating Hormone Market Drivers
8.3 Recombinant Follicle Stimulating Hormone Market Challenges
8.4 Recombinant Follicle Stimulating Hormone Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck Serono
MSD
Techwell
GenSci
Gedeon Richter
TEVA
List of Tables
 Table 1. Global Recombinant Follicle Stimulating Hormone Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Follicle Stimulating Hormone Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Follicle Stimulating Hormone Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Follicle Stimulating Hormone Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Follicle Stimulating Hormone Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Follicle Stimulating Hormone Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Follicle Stimulating Hormone Average Price (USD/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Follicle Stimulating Hormone, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Follicle Stimulating Hormone, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Follicle Stimulating Hormone, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Follicle Stimulating Hormone, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Follicle Stimulating Hormone as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Follicle Stimulating Hormone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Follicle Stimulating Hormone Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Follicle Stimulating Hormone Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Follicle Stimulating Hormone Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Follicle Stimulating Hormone Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Follicle Stimulating Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Follicle Stimulating Hormone Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Recombinant Follicle Stimulating Hormone Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Recombinant Follicle Stimulating Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Follicle Stimulating Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Follicle Stimulating Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Follicle Stimulating Hormone Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Recombinant Follicle Stimulating Hormone Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Follicle Stimulating Hormone Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Follicle Stimulating Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Recombinant Follicle Stimulating Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Follicle Stimulating Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Follicle Stimulating Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Recombinant Follicle Stimulating Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Follicle Stimulating Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2020-2025)
 Table 51. Global Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2026-2031)
 Table 52. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Follicle Stimulating Hormone Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Follicle Stimulating Hormone Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Type (2020-2025)
 Table 59. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Type (2026-2031)
 Table 60. Global Recombinant Follicle Stimulating Hormone Sales (K Doses) by Application (2020-2025)
 Table 61. Global Recombinant Follicle Stimulating Hormone Sales (K Doses) by Application (2026-2031)
 Table 62. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Follicle Stimulating Hormone Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Follicle Stimulating Hormone Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Application (2020-2025)
 Table 69. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Application (2026-2031)
 Table 70. Merck Serono Company Information
 Table 71. Merck Serono Description and Business Overview
 Table 72. Merck Serono Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 73. Merck Serono Recombinant Follicle Stimulating Hormone Product
 Table 74. Merck Serono Recent Developments/Updates
 Table 75. MSD Company Information
 Table 76. MSD Description and Business Overview
 Table 77. MSD Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 78. MSD Recombinant Follicle Stimulating Hormone Product
 Table 79. MSD Recent Developments/Updates
 Table 80. Techwell Company Information
 Table 81. Techwell Description and Business Overview
 Table 82. Techwell Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 83. Techwell Recombinant Follicle Stimulating Hormone Product
 Table 84. Techwell Recent Developments/Updates
 Table 85. GenSci Company Information
 Table 86. GenSci Description and Business Overview
 Table 87. GenSci Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. GenSci Recombinant Follicle Stimulating Hormone Product
 Table 89. GenSci Recent Developments/Updates
 Table 90. Gedeon Richter Company Information
 Table 91. Gedeon Richter Description and Business Overview
 Table 92. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 93. Gedeon Richter Recombinant Follicle Stimulating Hormone Product
 Table 94. Gedeon Richter Recent Developments/Updates
 Table 95. Teva Company Information
 Table 96. Teva Description and Business Overview
 Table 97. Teva Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 98. Teva Recombinant Follicle Stimulating Hormone Product
 Table 99. Teva Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Recombinant Follicle Stimulating Hormone Distributors List
 Table 103. Recombinant Follicle Stimulating Hormone Customers List
 Table 104. Recombinant Follicle Stimulating Hormone Market Trends
 Table 105. Recombinant Follicle Stimulating Hormone Market Drivers
 Table 106. Recombinant Follicle Stimulating Hormone Market Challenges
 Table 107. Recombinant Follicle Stimulating Hormone Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Follicle Stimulating Hormone
 Figure 2. Global Recombinant Follicle Stimulating Hormone Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Follicle Stimulating Hormone Market Share by Type: 2024 & 2031
 Figure 4. 75IU Product Picture
 Figure 5. 150IU Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Recombinant Follicle Stimulating Hormone Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Recombinant Follicle Stimulating Hormone Market Share by Application: 2024 & 2031
 Figure 9. Infertility Treatment
 Figure 10. Assisted Reproductive Technology
 Figure 11. Global Recombinant Follicle Stimulating Hormone Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Recombinant Follicle Stimulating Hormone Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Recombinant Follicle Stimulating Hormone Sales (2020-2031) & (K Doses)
 Figure 14. Global Recombinant Follicle Stimulating Hormone Average Price (USD/Dose) & (2020-2031)
 Figure 15. Recombinant Follicle Stimulating Hormone Report Years Considered
 Figure 16. Recombinant Follicle Stimulating Hormone Sales Share by Manufacturers in 2024
 Figure 17. Global Recombinant Follicle Stimulating Hormone Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Recombinant Follicle Stimulating Hormone Players: Market Share by Revenue in Recombinant Follicle Stimulating Hormone in 2024
 Figure 19. Recombinant Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Recombinant Follicle Stimulating Hormone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2020-2031)
 Figure 22. North America Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2020-2031)
 Figure 23. United States Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2020-2031)
 Figure 26. Europe Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2020-2031)
 Figure 34. China Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Recombinant Follicle Stimulating Hormone by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Recombinant Follicle Stimulating Hormone by Type (2020-2031)
 Figure 55. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Recombinant Follicle Stimulating Hormone by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Recombinant Follicle Stimulating Hormone by Application (2020-2031)
 Figure 58. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Application (2020-2031)
 Figure 59. Recombinant Follicle Stimulating Hormone Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Recombinant Human Follicle stimulating Hormone Market
Global Recombinant FSH Injections Market Research Report 2024
Global Follicle Stimulating Hormone FSH Injections Market Research Report 2024
Global Follicle Stimulating Hormone Market Research Report 2025
Global Recombinant Hormone Market Research Report 2024
Global Recombinant Human Follicle Stimulating Hormone Injection Market Research Report 2024
Follitropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Growth Hormone Market Research Report 2025
Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Somatropin for Injection Market Research Report 2024
Global Recombinant Growth Hormone Market Research Report 2024
Recombinant Human Chorionic Gonadotropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Insulin Market Insights Forecast to 2030
Global Recombinant Human Basic Fibroblast Growth Factor Market Research Report 2024
Human Chorionic Gonadotropin HCG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urinary Follicle Stimulating Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Therapeutic Protein Market Research Report 2025
Global Follicle Stimulating Hormone Test Kit Market Research Report 2024
Global DNA Vaccines Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions